Yüklüyor......
Anti-GD2 Strategy in the Treatment of Neuroblastoma
The prognosis for advanced neuroblastoma remains poor with high risk of recurrence after consolidation. Therapies based on monoclonal antibodies that specifically target disialoganglioside GD2 on tumor cells are improving treatment results for high-risk neuroblastoma. This article reviews the use of...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2964668/ https://ncbi.nlm.nih.gov/pubmed/21037966 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|